ACTRN12607000457448
Withdrawn
Phase 1
A randomised clinical control trial utilising a group treatment Program for the Psychological Difficulties Associated with Adolescent Diabetes (Type 1)
Queensland Department of Health0 sites160 target enrollmentSeptember 11, 2007
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Queensland Department of Health
- Enrollment
- 160
- Status
- Withdrawn
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Teenagers as participants aged\-between 13\-17 and having diabetes.
Exclusion Criteria
- •Significant mental health problems i.e. active suicidality, psychosis or inappropriateness to go on waitlist due to severity of presenting problem etc.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A clinical study to compare effect of kushmand choornavati with Tagar ghanvati as anxiolytic and sedative as pre-medication in spinal anaesthesiaHealth Condition 1: F409- Phobic anxiety disorder, unspecifiedCTRI/2020/01/022835PDEAS College of Ayurved and research centre
Not yet recruiting
Not Applicable
A clinical trial to study the effects of two procedures, shatpushpa siddha taila nasya and shatpushpa siddha taila matrabasti in patients with irregular menses and pcos.Health Condition 1: E282- Polycystic ovarian syndromeCTRI/2024/03/063784Chaitalee Rajendra Jain
Terminated
Phase 3
Varenicline alone or with nicotine e-cigarettes for smoking cessation in people with mental illness and drug and/or alcohol dependence.SmokingMental illnessDrug and alcohol dependenceMental Health - AddictionMental Health - Other mental health disordersACTRN12616001355460The University of Auckland15
Recruiting
Phase 2
A trial examining the use of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for children undergoing microlaryngoscopy and bronchoscopyRespiratory diseaseAnaesthesiology - AnaestheticsRespiratory - Other respiratory disorders / diseasesACTRN12617000799358Auckland District Health Board250
Completed
Not Applicable
A randomised controlled clinical trial to evaluate the anti-osteolytic agent clodronate for the prevention of the development of bone metastases in patients with primary breast cancerISRCTN83688026Royal Marsden Hospital (UK), secondary sponsor Schering (Germany)1,000